chrX-51895639-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_006986.4(MAGED1):āc.632A>Gā(p.Asp211Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000579 in 1,209,161 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_006986.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAGED1 | NM_006986.4 | c.632A>G | p.Asp211Gly | missense_variant | 3/13 | ENST00000326587.12 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAGED1 | ENST00000326587.12 | c.632A>G | p.Asp211Gly | missense_variant | 3/13 | 1 | NM_006986.4 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00000890 AC: 1AN: 112349Hom.: 0 Cov.: 24 AF XY: 0.0000290 AC XY: 1AN XY: 34515
GnomAD3 exomes AF: 0.00000555 AC: 1AN: 180107Hom.: 0 AF XY: 0.0000154 AC XY: 1AN XY: 64789
GnomAD4 exome AF: 0.00000547 AC: 6AN: 1096812Hom.: 0 Cov.: 32 AF XY: 0.00000552 AC XY: 2AN XY: 362220
GnomAD4 genome AF: 0.00000890 AC: 1AN: 112349Hom.: 0 Cov.: 24 AF XY: 0.0000290 AC XY: 1AN XY: 34515
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 19, 2024 | The c.800A>G (p.D267G) alteration is located in exon 4 (coding exon 3) of the MAGED1 gene. This alteration results from a A to G substitution at nucleotide position 800, causing the aspartic acid (D) at amino acid position 267 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at